Bodenrader Mark's Form 4 filing
Cerevel Therapeutics Holdings, Inc.CERE · filed Jun 5, 2023
- Accession no.
- 0000950170-23-026500
- Filed
- Jun 5, 2023
- Trade date
- Jun 1-2, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $62.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bodenrader MarkCIK 0001830371 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2023 | Common Stock | MOption exerciseAcquired | +4,733 | –F1 | – | 7,417 | Direct | |
| Jun 2, 2023 | Common Stock | SSaleDisposed | −1,895 | $32.95 | −$62,440.25 | 5,522 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2023 | Common Stock | MOption exerciseDisposed | −4,733 | $0.00 | $0 | 14,199 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement.
Referenced by the price of 1 transaction in Table I.
Remarks
Title: Senior Vice President, Finance and Chief Accounting Officer